Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 20, 2025

BUY
$65.25 - $83.83 $2.01 Million - $2.58 Million
30,752 Added 43.17%
101,979 $7.78 Million
Q4 2024

Feb 10, 2025

BUY
$66.29 - $76.63 $1.63 Million - $1.89 Million
24,634 Added 52.87%
71,227 $4.92 Million
Q3 2024

Nov 08, 2024

BUY
$62.0 - $79.01 $2.89 Million - $3.68 Million
46,593 New
46,593 $3.4 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $21.9B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.